Tumor-associated macrophages (TAMs) promote tumor progression in liver tissue microenvironments by releasing IL-6, which, in turn, activates the IL-6/STAT3 signaling pathway in nearby HCC stem cells [82]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.